These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 1569403

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX, Siegel JN, Gewurz H.
    J Immunol; 1991 Apr 01; 146(7):2324-30. PubMed ID: 2005402
    [Abstract] [Full Text] [Related]

  • 3. DNA binds and activates complement via residues 14-26 of the human C1q A chain.
    Jiang H, Cooper B, Robey FA, Gewurz H.
    J Biol Chem; 1992 Dec 15; 267(35):25597-601. PubMed ID: 1460055
    [Abstract] [Full Text] [Related]

  • 4. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region.
    McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A.
    J Immunol; 2006 Mar 01; 176(5):2950-7. PubMed ID: 16493053
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
    Ying SC, Gewurz AT, Jiang H, Gewurz H.
    J Immunol; 1993 Jan 01; 150(1):169-76. PubMed ID: 8417122
    [Abstract] [Full Text] [Related]

  • 7. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
    Agrawal A, Volanakis JE.
    J Immunol; 1994 Jun 01; 152(11):5404-10. PubMed ID: 8189060
    [Abstract] [Full Text] [Related]

  • 8. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
    Ji SR, Wu Y, Potempa LA, Liang YH, Zhao J.
    Arterioscler Thromb Vasc Biol; 2006 Apr 01; 26(4):935-41. PubMed ID: 16456095
    [Abstract] [Full Text] [Related]

  • 9. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
    Sjöwall C, Wetterö J, Bengtsson T, Askendal A, Almroth G, Skogh T, Tengvall P.
    Biochem Biophys Res Commun; 2007 Jan 05; 352(1):251-8. PubMed ID: 17113035
    [Abstract] [Full Text] [Related]

  • 10. Studies on the interactions between C-reactive protein and complement proteins.
    Bíró A, Rovó Z, Papp D, Cervenak L, Varga L, Füst G, Thielens NM, Arlaud GJ, Prohászka Z.
    Immunology; 2007 May 05; 121(1):40-50. PubMed ID: 17244159
    [Abstract] [Full Text] [Related]

  • 11. The phosphocholine and the polycation-binding sites on rabbit C-reactive protein are structurally and functionally distinct.
    Black S, Agrawal A, Samols D.
    Mol Immunol; 2003 Jun 05; 39(16):1045-54. PubMed ID: 12749911
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR, Hwang HY, Boackle RJ.
    Immunobiology; 2010 May 05; 215(5):395-405. PubMed ID: 19586684
    [Abstract] [Full Text] [Related]

  • 13. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
    Kovacs H, Campbell ID, Strong P, Johnson S, Ward FJ, Reid KB, Eggleton P.
    Biochemistry; 1998 Dec 22; 37(51):17865-74. PubMed ID: 9922153
    [Abstract] [Full Text] [Related]

  • 14. Heme interacts with c1q and inhibits the classical complement pathway.
    Roumenina LT, Radanova M, Atanasov BP, Popov KT, Kaveri SV, Lacroix-Desmazes S, Frémeaux-Bacchi V, Dimitrov JD.
    J Biol Chem; 2011 May 06; 286(18):16459-69. PubMed ID: 21454703
    [Abstract] [Full Text] [Related]

  • 15. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ.
    J Immunol; 1994 May 15; 152(10):5050-9. PubMed ID: 8176223
    [Abstract] [Full Text] [Related]

  • 16. Specific inhibition of the classical complement pathway by C1q-binding peptides.
    Roos A, Nauta AJ, Broers D, Faber-Krol MC, Trouw LA, Drijfhout JW, Daha MR.
    J Immunol; 2001 Dec 15; 167(12):7052-9. PubMed ID: 11739526
    [Abstract] [Full Text] [Related]

  • 17. Serum amyloid P component binds to histones and activates the classical complement pathway.
    Hicks PS, Saunero-Nava L, Du Clos TW, Mold C.
    J Immunol; 1992 Dec 01; 149(11):3689-94. PubMed ID: 1431140
    [Abstract] [Full Text] [Related]

  • 18. Topology and structure of the C1q-binding site on C-reactive protein.
    Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE.
    J Immunol; 2001 Mar 15; 166(6):3998-4004. PubMed ID: 11238646
    [Abstract] [Full Text] [Related]

  • 19. C1q binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14-26 of the human C1qA chain in a sequence independent manner.
    Bradley AJ, Brooks DE, Norris-Jones R, Devine DV.
    Biochim Biophys Acta; 1999 Apr 14; 1418(1):19-30. PubMed ID: 10209207
    [Abstract] [Full Text] [Related]

  • 20. Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis.
    Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C, Clos TW.
    J Biol Chem; 2005 Jul 01; 280(26):25095-102. PubMed ID: 15878871
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.